Supercritical Carbon Dioxide-Assisted Nebulization To Produce Fine Particles Of Stable Protein Formulations
Robert E. Sievers - American Association of Pharmaceutical Sciences Meeting, Arlington, Virginia, April, 2002
 1  2  3  4  5  6  7  8  9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32
next page

The CAN-BD process is based on the methods invented and developed by Sievers, Carpenter, and coworkers, licensed to AKTIV-DRY™

 
  • Sievers, R.E. and Karst, U. US Patent 5639441 (1997)
     
  • Sievers, R.E. and Karst, U. US Patent 6095134 (2000)
     
  • Sievers, R.E., Sellers, S.P. and Carpenter, J.F., WO 00/75281-A2 (2001); national phase entered in US, UK, Japan, Australia, China, Italy, Spain, Germany, France, Switzerland, etc.
     
  • Sievers, R.E. European patent 0677332 B2, Feb.27, 2002; registered in UK, Germany, France, Switzerland.
     
  • Other patent applications have been filed that are divisionals of the CAN-BD patent filed April 8, 1994, and the European application.
next page